top of page
Our Focus

Our Approach: Publications

OCE-205, a Novel, Selective Vasopressin (V1a) Receptor Mixed Agonist-Antagonist:  Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics from a Phase 1 Study
Allan Blemings, Yu Bagger, William R. Ravis, Geoff Harris

(233KB PDF)

AASLD Poster PresentationOcelot Bio
00:00 / 04:45
bottom of page